# European Alpha-Mannosidosis Participant

> **NCT03651245** · — · TERMINATED · sponsor: **CENTOGENE GmbH Rostock** · enrollment: 667 (actual)

## Conditions studied

- Immunodeficiency
- Skeletal Abnormalities
- Deafness
- Mental Retardation
- Gingival Hypertrophy
- Facial Dysmorphism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03651245
- **Lead sponsor:** CENTOGENE GmbH Rostock
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-20
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 667 (ACTUAL)
- **Why stopped:** we will update quickly
- **Last updated:** 2022-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03651245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03651245, "European Alpha-Mannosidosis Participant". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03651245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*